Free Trial

Krystal Biotech (KRYS) Short Interest Ratio & Short Volume

Krystal Biotech logo
$169.88 -0.69 (-0.40%)
As of 04:00 PM Eastern

Krystal Biotech Short Interest Data

Krystal Biotech (KRYS) has a short interest of 2.42 million shares, representing 9.80% of the float (the number of shares available for trading by the public). This marks a -10.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 295,802 shares to cover all short positions.

Current Short Interest
2,420,000 shares
Previous Short Interest
2,710,000 shares
Change Vs. Previous Month
-10.70%
Dollar Volume Sold Short
$409.29 million
Short Interest Ratio
8.5 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
28,898,000 shares
Short Percent of Float
9.80%
Today's Trading Volume
210,944 shares
Average Trading Volume
295,802 shares
Today's Volume Vs. Average
71%
Short Selling Krystal Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Krystal Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KRYS Short Interest Over Time

KRYS Days to Cover Over Time

KRYS Percentage of Float Shorted Over Time

Krystal Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20252,420,000 shares $409.29 million -10.7%9.8%8.5 $169.13
3/31/20252,710,000 shares $488.61 million +0.4%11.0%9.5 $180.30
3/15/20252,700,000 shares $484.33 million -2.2%10.9%9.9 $179.38
2/28/20252,760,000 shares $494.73 million -13.5%11.2%9.9 $179.25
2/15/20253,190,000 shares $488.84 million +6.0%12.9%11.9 $153.24
1/31/20253,010,000 shares $480.82 million -7.4%N/A11.5 $159.74
1/15/20253,250,000 shares $475.93 million -3.6%N/A12.2 $146.44
12/31/20243,370,000 shares $527.94 million -8.9%N/A13.6 $156.66
12/15/20243,700,000 shares $605.47 million +1.4%N/A15.4 $163.64
11/30/20243,650,000 shares $720.58 million +1.4%N/A15.5 $197.42
11/15/20243,600,000 shares $614.66 million +4.4%N/A15.7 $170.74
10/31/20243,450,000 shares $595.23 million -2.5%N/A16.1 $172.53
10/15/20243,540,000 shares $631.75 million +0.6%N/A15.6 $178.46
9/30/20243,520,000 shares $640.75 million -4.1%N/A13.9 $182.03
9/15/20243,670,000 shares $739.80 million -0.5%N/A12.9 $201.58
8/31/20243,690,000 shares $719.99 million +4.2%N/A9.5 $195.12
8/15/20243,540,000 shares $686.69 million +1.1%N/A9.1 $193.98
7/31/20243,500,000 shares $729.61 million -4.6%N/A8.8 $208.46
7/15/20243,670,000 shares $762.92 million +4.6%N/A9.4 $207.88
6/30/20243,510,000 shares $644.58 million +21.0%N/A9.1 $183.64
6/15/20242,900,000 shares $515.56 million +7.8%N/A7.7 $177.78
5/31/20242,690,000 shares $430.53 million -4.3%N/A8.6 $160.05
5/15/20242,810,000 shares $458.56 million +8.5%N/A7.5 $163.19
4/30/20242,590,000 shares $396.58 million +5.7%N/A6.6 $153.12
4/15/20242,450,000 shares $415.89 million +12.9%N/A6.2 $169.75
3/31/20242,170,000 shares $386.11 million -3.1%N/A5.5 $177.93
3/15/20242,240,000 shares $387.48 million -10.8%N/A5.8 $172.98
2/29/20242,510,000 shares $400.27 million +1.6%N/A6.5 $159.47
2/15/20242,470,000 shares $280.05 million +21.7%N/A7.3 $113.38
1/31/20242,030,000 shares $225.84 million +3.1%N/A6.6 $111.25
1/15/20241,970,000 shares $252.87 million -9.2%N/A6.3 $128.36
12/31/20232,170,000 shares $269.21 million +11.3%N/A7.1 $124.06
12/15/20231,950,000 shares $225.73 million -8.0%N/A6.4 $115.76
11/30/20232,120,000 shares $220.97 million +2.4%N/A6.8 $104.23
11/15/20232,070,000 shares $206.09 million -1.4%N/A6.8 $99.56
10/31/20232,100,000 shares $245.43 million +7.1%N/A7.1 $116.87
10/15/20231,960,000 shares $223.01 million -0.5%N/A7.4 $113.78
9/30/20231,970,000 shares $228.52 million +23.9%N/A7.4 $116.00
9/15/20231,590,000 shares $191.07 million +6.0%N/A5.9 $120.17
8/31/20231,500,000 shares $186.72 million -2.6%N/A5.7 $124.48
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
8/15/20231,540,000 shares $187.82 million +15.8%N/A5.3 $121.96
7/31/20231,330,000 shares $171.70 million -7.6%N/A4.1 $129.10
7/15/20231,440,000 shares $181.83 million +6.7%6.8%4.7 $126.27
6/30/20231,350,000 shares $158.49 million +3.1%6.4%4.5 $117.40
6/15/20231,310,000 shares $163.37 million +10.1%6.2%4.3 $124.71
5/31/20231,190,000 shares $140.24 million +3.5%5.6%4.3 $117.85
5/15/20231,150,000 shares $103.56 million -0.9%5.5%4.4 $90.05
4/30/20231,160,000 shares $97.44 million -7.2%5.5%5.7 $84.00
4/15/20231,250,000 shares $107.98 million +4.2%6.0%6.4 $86.38
3/31/20231,200,000 shares $96.07 million +5.3%5.8%5.9 $80.06
3/15/20231,140,000 shares $83.80 million -4.2%5.5%5.9 $73.51
2/28/20231,190,000 shares $97.47 million +6.3%5.7%6.3 $81.91
2/15/20231,120,000 shares $82.33 million +6.7%5.4%6.5 $73.51
1/31/20231,050,000 shares $87.28 million -7.1%5.1%6.1 $83.12
1/15/20231,130,000 shares $93.73 million +14.4%5.4%6.5 $82.95
12/30/2022988,100 shares $78.28 million -10.2%4.8%5.9 $79.22
12/15/20221,100,000 shares $86.24 million -9.1%5.3%6.9 $78.40
11/30/20221,210,000 shares $94.07 million -3.2%5.9%7.8 $77.74
11/15/20221,250,000 shares $96.51 million -4.6%6.1%7.7 $77.21
10/31/20221,310,000 shares $100.22 million +3.2%6.4%7.9 $76.50
10/15/20221,270,000 shares $83.83 million -3.1%6.2%7.6 $66.01
9/30/20221,310,000 shares $91.31 million +7.4%6.4%7.9 $69.70
9/15/20221,220,000 shares $86.97 million -4.7%6.3%7.3 $71.29
8/31/20221,280,000 shares $89.74 million -5.9%6.6%7.2 $70.11
8/15/20221,360,000 shares $105.48 million -0.7%7.0%7.9 $77.56
7/31/20221,370,000 shares $99.43 million -1.4%7.0%7.5 $72.58
7/15/20221,390,000 shares $100.66 million -10.9%7.1%7.7 $72.42
6/30/20221,560,000 shares $102.43 million -2.5%7.9%8.6 $65.66
6/15/20221,600,000 shares $85.34 million +0.6%8.1%8.4 $53.34
5/31/20221,590,000 shares $93.62 million -1.2%8.1%7.8 $58.88
5/15/20221,610,000 shares $90.77 million +2.6%8.2%7.6 $56.38
4/30/20221,570,000 shares $95.16 million -7.1%8.1%7.4 $60.61
4/15/20221,690,000 shares $122.51 million +5.0%8.7%8 $72.49
3/31/20221,610,000 shares $107.13 million +17.5%8.4%7.2 $66.54
3/15/20221,370,000 shares $84.98 million +13.2%7.1%6.3 $62.03
2/28/20221,210,000 shares $76.90 million +4.3%6.4%5.2 $63.55
2/15/20221,160,000 shares $78.11 million +9.4%N/A2.6 $67.34
1/31/20221,060,000 shares $62.54 million -1.9%5.6%2.4 $59.00
1/15/20221,080,000 shares $67.26 million +4.9%5.7%2.4 $62.28
12/31/20211,030,000 shares $72.05 million -25.4%5.4%2.4 $69.95
12/15/20211,380,000 shares $99.98 million -37.6%7.3%3.3 $72.45
11/30/20212,210,000 shares $178.02 million +6.8%12.3%5.7 $80.55
11/15/20212,070,000 shares $98.22 million +12.5%12.9%13.6 $47.45
10/29/20211,840,000 shares $92.17 million +5.8%11.5%14.2 $50.09
10/15/20211,740,000 shares $84.77 million +13.0%10.8%15 $48.72
9/30/20211,540,000 shares $80.40 million -0.7%9.6%13.6 $52.21
9/15/20211,550,000 shares $86.89 million -4.3%9.7%12.5 $56.06
8/31/20211,620,000 shares $93.86 million +12.5%10.1%12.6 $57.94
8/13/20211,440,000 shares $80.90 million +7.5%9.0%11.6 $56.18
7/30/20211,340,000 shares $78.31 million +24.1%8.4%10.9 $58.44
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
7/15/20211,080,000 shares $67.46 million -1.8%6.8%9.3 $62.46
6/30/20211,100,000 shares $74.80 million -4.4%6.9%10.1 $68.00
6/15/20211,150,000 shares $72.91 million -0.9%7.2%11.8 $63.40
5/28/20211,160,000 shares $75.68 million -4.1%7.3%11.5 $65.24
5/14/20211,210,000 shares $75.67 million -2.4%7.6%10.7 $62.54
4/30/20211,240,000 shares $99.35 million +3.3%7.8%9.2 $80.12
4/15/20211,200,000 shares $89.72 million -3.2%7.5%8 $74.77
3/31/20211,240,000 shares $90.43 million +6.9%7.9%8 $72.93
3/15/20211,160,000 shares $96.06 million -2.5%7.4%7.1 $82.81
2/26/20211,190,000 shares $93.87 million +10.2%7.9%7.3 $78.88
2/12/20211,080,000 shares $74.19 million -10.7%7.2%6.5 $68.69
1/29/20211,210,000 shares $85.51 million -6.2%8.1%7.3 $70.67
1/15/20211,290,000 shares $85.58 million -5.8%9.6%8.6 $66.34
12/31/20201,370,000 shares $82.76 million +2.2%10.2%9.3 $60.41
12/15/20201,340,000 shares $78.26 million -2.2%10.0%9 $58.40
11/30/20201,370,000 shares $66.94 million -4.2%10.2%9.8 $48.86
11/15/20201,430,000 shares $59.89 million -7.1%10.7%10.6 $41.88
10/30/20201,540,000 shares $69.79 million -11.0%11.5%12.1 $45.32
10/15/20201,730,000 shares $86.60 million -3.9%13.0%13.6 $50.06
9/30/20201,800,000 shares $77.49 million +8.4%13.5%14.1 $43.05
9/15/20201,660,000 shares $76.71 million +1.8%12.4%11.7 $46.21
8/31/20201,630,000 shares $77.93 million +4.5%12.3%10.8 $47.81
8/14/20201,560,000 shares $66.46 million -3.7%11.7%9.6 $42.60
7/31/20201,620,000 shares $66.89 million +2.5%12.2%8.5 $41.29
7/15/20201,580,000 shares $63.37 million No Change11.9%8.5 $40.11
6/30/20201,580,000 shares $65.25 million +29.5%12.7%7.9 $41.30
6/15/20201,220,000 shares $55.47 million +3.4%9.8%6.3 $45.47
5/29/20201,180,000 shares $59.44 million -8.5%10.8%6.1 $50.37
5/15/20201,290,000 shares $76.37 million -9.2%11.8%6.7 $59.20
4/30/20201,420,000 shares $67.01 million -6.0%13.0%9.1 $47.19

KRYS Short Interest - Frequently Asked Questions

What is Krystal Biotech's current short interest?

Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,420,000 shares of KRYS short. 9.80% of Krystal Biotech's shares are currently sold short. Learn More on Krystal Biotech's current short interest.

What is a good short interest ratio for Krystal Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRYS shares currently have a short interest ratio of 8.0. Learn More on Krystal Biotech's short interest ratio.

Which institutional investors are shorting Krystal Biotech?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Krystal Biotech: Wolverine Trading LLC, Millennium Management LLC, LMR Partners LLP, Caption Management LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Jane Street Group LLC, Nantahala Capital Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Krystal Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.80% of Krystal Biotech's floating shares are currently sold short.

Is Krystal Biotech's short interest increasing or decreasing?

Krystal Biotech saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 2,420,000 shares, a decrease of 10.7% from the previous total of 2,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Krystal Biotech's short interest compare to its competitors?

9.80% of Krystal Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Krystal Biotech: Summit Therapeutics Inc. (29.08%), Teva Pharmaceutical Industries Limited (2.69%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.33%), Dr. Reddy's Laboratories Limited (1.91%), Ascendis Pharma A/S (11.37%), Moderna, Inc. (16.48%), Viatris Inc. (3.96%), Qiagen (2.11%), Roivant Sciences Ltd. (11.68%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Krystal Biotech stock?

Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. KRYS shares are trading down $1.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Krystal Biotech?

A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further.

How often is Krystal Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:KRYS) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners